Stay updated on Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:56.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    No substantive changes detected in core content; study details, eligibility criteria, and outcome measures appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-26T12:14:51.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing v3.4.3; no study content or user functionality is affected.
    Difference
    0.1%
    Check dated 2026-03-19T08:26:48.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    - Revision tag updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:39:58.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added a new condition term, Primary peritoneal carcinoma, and a new external resource (Genetic and Rare Diseases Information Center) for patient education. The page update also includes a new Revision (v3.4.2) and removal of the prior funding-notice (v3.4.1).
    Difference
    0.6%
    Check dated 2026-02-11T14:26:15.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Added a government funding notice indicating the NIH Clinical Center is open. Updated the page to Revision: v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-04T10:29:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.